BeatO

Series-B+
beatoapp.com Biotech & Healthcare
Total Funding $33M
Latest Round $33M Series-B+
Last Announced Nov 16, 2022
Investors Undisclosed
Decision Makers 6 Verified

About BeatO

India’s most trusted D2C platform for CGM-powered diabetes care and GLP-1 weight loss support. Explore smart health devices, personalized diabetes programs, healthy food options, protein, fiber, and supplements designed for better glucose control and sustainable weight management.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website beatoapp.com
Domain Registered Date Sep 7, 2015

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $33,000,000 · Series-B+

    startupintros.com

  2. Milestone

    Website domain registered

    beatoapp.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for BeatO.

Funding History

1 Round
Series-B+ · Nov 16, 2022

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts